JP2010523592A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523592A5
JP2010523592A5 JP2010502317A JP2010502317A JP2010523592A5 JP 2010523592 A5 JP2010523592 A5 JP 2010523592A5 JP 2010502317 A JP2010502317 A JP 2010502317A JP 2010502317 A JP2010502317 A JP 2010502317A JP 2010523592 A5 JP2010523592 A5 JP 2010523592A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding fragment
seq
endosialin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523592A (ja
JP5825784B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059374 external-priority patent/WO2008124570A1/en
Publication of JP2010523592A publication Critical patent/JP2010523592A/ja
Publication of JP2010523592A5 publication Critical patent/JP2010523592A5/ja
Application granted granted Critical
Publication of JP5825784B2 publication Critical patent/JP5825784B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502317A 2007-04-05 2008-04-04 エンドシアリンのリガンドへの結合を阻害する方法 Active JP5825784B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US91036207P 2007-04-05 2007-04-05
US60/910,362 2007-04-05
US98002607P 2007-10-15 2007-10-15
US60/980,026 2007-10-15
PCT/US2008/059374 WO2008124570A1 (en) 2007-04-05 2008-04-04 Methods for inhibiting the binding of endosialin to ligands

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013041304A Division JP2013150618A (ja) 2007-04-05 2013-03-01 エンドシアリンのリガンドへの結合を阻害する方法

Publications (3)

Publication Number Publication Date
JP2010523592A JP2010523592A (ja) 2010-07-15
JP2010523592A5 true JP2010523592A5 (enExample) 2011-09-15
JP5825784B2 JP5825784B2 (ja) 2015-12-02

Family

ID=39714208

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010502317A Active JP5825784B2 (ja) 2007-04-05 2008-04-04 エンドシアリンのリガンドへの結合を阻害する方法
JP2013041304A Pending JP2013150618A (ja) 2007-04-05 2013-03-01 エンドシアリンのリガンドへの結合を阻害する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013041304A Pending JP2013150618A (ja) 2007-04-05 2013-03-01 エンドシアリンのリガンドへの結合を阻害する方法

Country Status (20)

Country Link
US (4) US7807382B2 (enExample)
EP (2) EP2137217B1 (enExample)
JP (2) JP5825784B2 (enExample)
KR (1) KR101529334B1 (enExample)
CN (1) CN101918446B (enExample)
AU (1) AU2008237296B2 (enExample)
BR (1) BRPI0809665B8 (enExample)
CA (1) CA2682726C (enExample)
CY (2) CY1115370T1 (enExample)
DK (2) DK2620451T3 (enExample)
ES (2) ES2452929T3 (enExample)
HR (2) HRP20140266T1 (enExample)
HU (1) HUE031269T2 (enExample)
LT (1) LT2620451T (enExample)
MX (1) MX2009010701A (enExample)
PL (2) PL2620451T3 (enExample)
PT (2) PT2620451T (enExample)
RS (2) RS55447B1 (enExample)
SI (2) SI2137217T1 (enExample)
WO (1) WO2008124570A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615372B2 (en) * 2005-04-22 2009-11-10 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
PL2620451T3 (pl) * 2007-04-05 2017-06-30 Morphotek, Inc. Sposoby hamowania wiązania endosjaliny do ligandów
US8697081B2 (en) * 2008-04-09 2014-04-15 The Regents Of The University Of Michigan Method of modulating neovascularization
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
WO2011060233A1 (en) 2009-11-11 2011-05-19 The Trustees Of The University Of Pennsylvania Anti-tem1 antibodies and uses thereof
JP2013543379A (ja) 2010-09-29 2013-12-05 モルフォテック， インコーポレイテッド 操作されたヒトエンドシアリン発現齧歯動物
WO2013148250A1 (en) * 2012-03-30 2013-10-03 Morphotek, Inc. Tem-1 diagnostic antibodies
WO2013162748A1 (en) * 2012-04-27 2013-10-31 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
HK1219980A1 (zh) 2013-03-09 2017-04-21 Baylor College Of Medicine 靶向血管的t细胞疗法
GB201702926D0 (en) * 2017-02-23 2017-04-12 Univ Birmingham Modulators
IL322622A (en) 2017-07-28 2025-10-01 Applied Therapeutics Inc Preparations and methods for treating galactosemia
CN110531077B (zh) * 2018-05-25 2023-07-07 荣昌生物制药(烟台)股份有限公司 间皮素免疫组化检测试剂盒
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
JP7623292B2 (ja) 2019-04-01 2025-01-28 アプライド セラピューティクス， インコーポレイテッド アルドースレダクターゼの阻害剤
MX2021013511A (es) 2019-05-07 2022-02-23 Univ Miami Tratamiento y deteccion de neuropatias heredadas y trastornos asociados.
CN111026023A (zh) * 2020-01-12 2020-04-17 安徽楚江科技新材料股份有限公司 基于s7-400控制系统的铜带轧机PLC组态方法
CN116790744B (zh) * 2023-06-30 2024-04-26 浙江大学 一种缺血性心脏病晚期纤维化干预靶点及其应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5342757A (en) 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
EP0686260B1 (en) 1993-02-05 2003-07-09 Epigen, Inc. Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
WO1995024483A1 (en) * 1994-03-08 1995-09-14 Scotgen Biopharmaceuticals, Inc. Recombinant humanized anti-fb5 antibodies
DE19541844C1 (de) 1995-11-09 1997-07-24 Gsf Forschungszentrum Umwelt Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung
US6146894A (en) 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
EP1112020A1 (en) 1998-09-09 2001-07-04 U.S. Army Institute of Surgical Research Method for monitoring arterial oxygen saturation
WO2001068911A2 (en) * 2000-03-15 2001-09-20 Epigenomics Ag Diagnosis of diseases associated with the cell cycle
AU2001283062A1 (en) * 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
CA2434926C (en) 2001-01-15 2014-04-01 Morphotek, Inc. Chemical inhibitors of mismatch repair
US20040043928A1 (en) * 2001-08-02 2004-03-04 Ramesh Kekuda Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030124579A1 (en) * 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20040014058A1 (en) * 2001-10-05 2004-01-22 Alsobrook John P. Novel human proteins, polynucleotides encoding them and methods of using the same
EP2236614A3 (en) * 2002-08-15 2011-01-26 Genzyme Corporation Brain endothelial cell expression patterns
US20040253606A1 (en) * 2002-11-26 2004-12-16 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
EP2264073A1 (en) 2003-03-04 2010-12-22 Kirin Beer Kabushiki Kaisha Endothelial cell specific antibodies and uses thereof
WO2005086713A2 (en) * 2004-03-04 2005-09-22 Kirin Brewery Co., Ltd. Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
WO2006017759A2 (en) 2004-08-05 2006-02-16 Kirin Brewery Co., Ltd. Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof
WO2006029045A2 (en) 2004-09-03 2006-03-16 Kirin Brewery Co., Ltd. Endothelial cell specific antibodies and uses thereof
ATE493152T1 (de) * 2004-09-23 2011-01-15 Guerbet Sa Liposomale kontrastmittel für die cest-bildgebung
WO2006060719A2 (en) 2004-12-03 2006-06-08 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
EP1856278A2 (en) * 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
US7615372B2 (en) 2005-04-22 2009-11-10 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
US7315372B1 (en) * 2005-09-29 2008-01-01 The United States Of America As Represented By The Secretary Of The Navy Instrument using near-field intensity correlation measurements for characterizing scattering of light by suspensions
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US7908090B2 (en) * 2005-11-30 2011-03-15 The Board Of Trustees Of The Leland Stanford Junior University Signatures for human aging
JP2009523709A (ja) * 2005-12-16 2009-06-25 ジェネンテック・インコーポレーテッド 神経膠腫の診断、予後の予測及び治療の方法
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
US20090239223A1 (en) * 2006-07-13 2009-09-24 Siemens Healthcare Diagnostics Inc. Prediction of Breast Cancer Response to Taxane-Based Chemotherapy
EP2049713A4 (en) * 2006-07-21 2010-06-16 Univ Alberta tissue rejection
ES2421354T3 (es) 2006-08-11 2013-08-30 Johns Hopkins University Secuencias consenso codificantes de cánceres de mama y colorrectales humanos
US20080300170A1 (en) * 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes
WO2008063479A2 (en) * 2006-11-17 2008-05-29 Fred Hutchinson Cancer Research Center Pancreatic cancer biomarkers
WO2008097908A2 (en) 2007-02-05 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods of diagnosing and prognosing lung cancer
WO2008101118A2 (en) 2007-02-14 2008-08-21 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates
EP1986010A1 (en) 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Methods and tools for discriminating colorectal adenomas and adenocarcinomas
PL2620451T3 (pl) * 2007-04-05 2017-06-30 Morphotek, Inc. Sposoby hamowania wiązania endosjaliny do ligandów
JP5769417B2 (ja) 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 腫瘍細胞由来微小胞
DK2245199T3 (da) * 2008-02-01 2014-02-03 Gen Hospital Corp Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande
EP2250287B1 (en) 2008-02-19 2013-09-18 MDxHealth SA Detection and prognosis of lung cancer
WO2009120877A2 (en) 2008-03-26 2009-10-01 The Johns Hopkins University Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
US20100092470A1 (en) * 2008-09-22 2010-04-15 Icb International, Inc. Antibodies, analogs and uses thereof
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
US20110256560A1 (en) 2008-10-20 2011-10-20 University Health Network Methods and compositions for the detection of ovarian cancer
NZ624816A (en) 2009-01-14 2015-07-31 Us Health Ratio based biomarkers and methods of use thereof
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules

Similar Documents

Publication Publication Date Title
JP2010523592A5 (enExample)
JP2012523848A5 (enExample)
JP2013544756A5 (enExample)
HRP20190762T1 (hr) Protutijela koja se vežu prvenstveno na izvanstaničnu domenu 4 ljudskog csf1r i njihova uporaba
JP2009518039A5 (enExample)
JP2013545455A5 (enExample)
JP2013506428A5 (enExample)
JP2010538608A5 (enExample)
JP2016507523A5 (enExample)
JP2010533498A5 (enExample)
JP2012525854A5 (enExample)
JP2020517249A5 (enExample)
RU2018128414A (ru) Новое psma-связывающее антитело и его применения
RU2009126766A (ru) Антитела человека к дельта-подобному лиганду-4 человека
JP2017522892A5 (enExample)
JP2016512551A5 (enExample)
JP2015533853A5 (enExample)
JP2016512521A5 (enExample)
JP2018507188A5 (enExample)
NZ597067A (en) Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer
JP2005518336A5 (enExample)
JP2017149720A5 (enExample)
JP2018516853A5 (enExample)
JP2010526028A5 (enExample)
JP2014518615A5 (enExample)